Rocuronium Bromide Injection
Brand names: Rocuronium, Rocuronium Bromide
Category: Anesthesia
Unavailable 2Limited 1Available 23
FDA status: Current · Last FDA update: Sep 22, 2026 · First posted: Feb 15, 2023 (in shortage 3 years 7 months) · 11 manufacturers, 26 listed presentations
As of Sep 22, 2026, the FDA lists Rocuronium Bromide Injection as currently in shortage. Of 26 manufacturer presentations, 2 Unavailable, 1 Limited, 23 Available.
Ask your pharmacist: which of the 11 manufacturers below can they order right now, and whether a different strength or form of Rocuronium Bromide Injection is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-065-05) NDC 65219-065-05 |
Fresenius Kabi USA, LLC | Unavailable | Estimated recovery: TBD |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-05) NDC 63323-426-05 |
Fresenius Kabi USA, LLC | Unavailable | Next release October 2026. Check wholesalers for inventory. |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-442-05) NDC 65219-442-05 |
Fresenius Kabi USA, LLC | Available | Check wholesalers for inventory |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-444-10) NDC 65219-444-10 |
Fresenius Kabi USA, LLC | Available | Check wholesalers for inventory |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-10) NDC 63323-426-10 |
Fresenius Kabi USA, LLC | Available | Check wholesalers for inventory |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9251-10) NDC 0143-9251-10 |
Hikma Pharmaceuticals USA, Inc. | Available | Additional lots will be available. Product will be made available as it is released. |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9250-10) NDC 0143-9250-10 |
Hikma Pharmaceuticals USA, Inc. | Available | Additional lots will be available. Product will be made available as it is released. |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-700-06) NDC 71288-700-06 |
Meitheal Pharmaceuticals, Inc. | Available | - |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-718-11) NDC 71288-718-11 |
Meitheal Pharmaceuticals, Inc. | Available | - |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-10) NDC 67457-228-10 |
Mylan Institutional, a Viatris Company | Available | - |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-05) NDC 67457-228-05 |
Mylan Institutional, a Viatris Company | Available | - |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 25021-687-05) NDC 25021-687-05 |
Sagent Pharmaceuticals | Available | - |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-92) NDC 0781-3220-92 |
Sandoz Inc. | Available | - |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-95) NDC 0781-3220-95 |
Sandoz Inc. | Available | - |
| Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 43066-007-10) NDC 43066-007-10 |
Baxter Healthcare | Available | - |
| Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 55150-225-05) NDC 55150-225-05 |
Eugia US LLC | Available | Check wholesalers for inventory |
| Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 66794-228-41) NDC 66794-228-41 |
Piramal Critical Care Inc. | Available | - |
| Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 39822-4200-2) NDC 39822-4200-2 |
XGen Pharmaceuticals DJB, Inc. | Available | Tamarang is the application holder and X-Gen is the distributor/labeler |
| Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 66794-229-41) NDC 66794-229-41 |
Piramal Critical Care Inc. | Limited | On allocation |
| Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 43066-013-10) NDC 43066-013-10 |
Baxter Healthcare | Available | - |
| Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 55150-226-10) NDC 55150-226-10 |
Eugia US LLC | Available | Check wholesalers for inventory |
| Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 39822-4200-6) NDC 39822-4200-6 |
XGen Pharmaceuticals DJB, Inc. | Available | Tamarang is the application holder and X-Gen is the distributor/labeler |
| Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-5160-10) NDC 0409-5160-10 |
Hospira, Inc., a Pfizer Company | Available | - |
| Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-7037-10) NDC 0409-7037-10 |
Hospira, Inc., a Pfizer Company | Available | - |
| Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-1403-10) NDC 0409-1403-10 |
Hospira, Inc., a Pfizer Company | Available | - |
| Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-3189-10) NDC 0409-3189-10 |
Hospira, Inc., a Pfizer Company | Available | - |
Related medications in shortage
Other Anesthesia medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Rocuronium Bromide Injection (FDA data as of Sep 22, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Rocuronium Bromide Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Check your inbox - click the confirmation link to activate
alerts for Rocuronium Bromide Injection.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/rocuronium-bromide-injection.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).